Publication of Cancellation of Entries for Kinds of Medical Devices from the Australian Register of Therapeutic Goods - Gelpal, Surrey Hills, NSW - 185076

Overview

The Therapeutic Goods Act 1989 was enacted to provide a regulatory framework for therapeutic goods in Australia, including medicines, medical devices, and blood and blood components. This Act was introduced to address the need for ensuring the safety, quality, and efficacy of therapeutic goods available to the public. The Act was passed by the Parliament of Australia and is administered by the Therapeutic Goods Administration (TGA), an agency of the Department of Health. The primary policy objective of the Act is to protect public health by regulating the supply and advertising of therapeutic goods. In a specific instance, the Act allows for the cancellation of entries for kinds of medical devices from the Australian Register of Therapeutic Goods (ARTG) if certain criteria are not met. The cancellation, as detailed in the gazette, was made under section 41GP of the Act due to non-compliance with labelling requirements, lack of evidence for conformity assessment procedures, and breaches in promotional material as per the Therapeutic Goods Advertising Code 2007. This ensures that only therapeutic goods that meet the necessary standards are available to consumers.

Scope and Application

The Therapeutic Goods Act 1989, as administered by the Therapeutic Goods Administration (TGA), applies to medical devices intended for therapeutic use in Australia, including their manufacture, supply, and advertisement. This legislation governs the regulation of therapeutic goods to ensure their safety, quality, and efficacy. The Act applies to all persons and entities involved in the manufacture, supply, importation, and advertisement of therapeutic goods, including medical devices. Its jurisdictional reach is national, as it is a Commonwealth Act applicable across Australia. The Act's application is comprehensive, covering all therapeutic goods sold, supplied, or advertised within the country. However, the Act also includes specific exclusions and exemptions, such as for goods used for personal, non-commercial purposes or certain goods intended for research purposes. The scope of the Act can be extended or restricted through subordinate instruments, such as regulations and codes, which provide detailed requirements and guidelines for compliance. In this instance, the cancellation of an entry from the Australian Register of Therapeutic Goods highlights the Act's enforcement mechanisms to maintain high standards of therapeutic goods in the market.

Key Provisions

The Therapeutic Goods Act 1989, under section 41GP, authorises the cancellation of entries for kinds of medical devices from the Australian Register of Therapeutic Goods (ARTG) when certain criteria are met (sections 41GN(1)(f) and 41GP). This legislative tool allows the Therapeutic Goods Administration (TGA) to ensure that only those medical devices meeting the required standards and certifications are available on the market. In this specific instance, the cancellation pertains to a reusable hot/cold compress with the ARTG number 185076, sponsored by Gelpal from Surrey Hills, NSW, and manufactured by Taiwan Stanch Co Ltd. The cancellation became effective on 24 September 2013. Under the Act, the obligations of the sponsor and manufacturer are paramount. The sponsor, Gelpal, and the manufacturer, Taiwan Stanch Co Ltd, are required to ensure that all certifications and submissions to the TGA are accurate and comply with the stipulated regulations and codes. This includes providing evidence that the product conforms to the essential principles outlined in Schedule 1 of the Therapeutic Goods Regulations 1990 and adhering to the Therapeutic Goods Advertising Code 2007. Failure to meet these obligations can lead to the cancellation of the product's ARTG entry. Failure to meet the statutory obligations can result in significant consequences. The Act stipulates that incorrect certifications can lead to the cancellation of the product's entry from the ARTG. This means that the product can no longer be legally supplied in Australia, impacting both the manufacturer and the sponsor. Additionally, continued supply of a product whose ARTG entry has been cancelled can lead to further enforcement actions, including fines and potential legal proceedings. The precise penalties for such breaches are not detailed within the Act but can be substantial and are determined by the relevant courts and regulatory authorities.